Remus Pharmaceuticals Limited's latest marketcap:
As of 07/25/2025, Remus Pharmaceuticals Limited's market capitalization has reached $131.94 M. According to our data, Remus Pharmaceuticals Limited is the 23022th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | $131.94 M |
Revenue (ttm) | $71.74 M |
Net Income (ttm) | $3.36 M |
Shares Out | 11.78 M |
EPS (ttm) | $0.38 |
Forward PE | 0.00 |
Ex-Dividend Date | 11/19/2024 |
Earnings Date | 08/08/2025 |
Remus Pharmaceuticals Limited's yearly market capitalization.
Date | Market Cap(₹) | Market Cap(USD) | Change (%) | Global Rank |
---|---|---|---|---|
07/25/2025 | ₹11.41 B | $131.94 M | -22.47% | 23022 |
12/31/2024 | ₹14.72 B | $171.9 M | 30.53% | 19912 |
12/29/2023 | ₹11.27 B | $135.51 M | 21163 |
Company Profile
About Remus Pharmaceuticals Limited
Remus Pharmaceuticals Limited is a pharmaceutical company specializing in the marketing, trading, and distribution of finished formulations and products across India and international markets.
Core Business Activities
- Marketing and distribution of pharmaceutical formulations.
- Trading of active pharmaceutical ingredients (APIs).
- Providing technical consultancy services to distributors.
- Offering contract manufacturing services.
Product Portfolio
The company offers a diverse range of pharmaceutical products, including:
- Capsules, creams, and gels
- Eye drops, infusions, and inhalations
- Injections, nasal sprays, and nebulizers
- Ointments, ophthalmic solutions, and oral suspensions
- Sachets, tablets, and more
Global Presence
Remus Pharmaceuticals operates in multiple countries, including:
- Bhutan, Bolivia, Chile, and Costa Rica
- Cuba, Dominican Republic, Ecuador, and El Salvador
- Guatemala, Honduras, Jamaica, and Kuwait
- Madagascar, Malaysia, Hong Kong, and Myanmar
- Panama, Trinidad and Tobago, Uzbekistan, Venezuela, and Vietnam
Company Background
Originally incorporated in 2015 as Remus Pharmaceuticals Private Limited, the company rebranded to Remus Pharmaceuticals Limited in January 2023. It is headquartered in Ahmedabad, India.
Frequently Asked Questions
-
What is Remus Pharmaceuticals Limited's (NSE-REMUS) current market cap?As of 07/25/2025, Remus Pharmaceuticals Limited (including the parent company, if applicable) has an estimated market capitalization of $131.94 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Remus Pharmaceuticals Limited (NSE-REMUS) rank globally by market cap?Remus Pharmaceuticals Limited global market capitalization ranking is approximately 23022 as of 07/25/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.